IVERS-READ GILLIAN C (See Remarks) sold 0.8% of their position (2.23K shares) of CLOVIS ONCOLOGY, INC. on the open market
Open‑market sale worth $2.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/6/2022ACC: 0000899243-22-030418
Officer· See Remarks
Since Sep 2018
+7.89K
Net shares
Net buyer
$2.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
10.13K acquired · 2.23K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+5.06K
Price / share
—
Trade value
—
% of position
1.8%
9/1/2022
286.09K→291.15K
Common Stock
Direct
Shares
−2.23K
Price / share
$1.20
Trade value
$2.68K
% of position
0.8%
9/2/2022
291.15K→288.92K
Total
Net shares
+2.83K
Net value
-$2.68K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/1/2022 | M · Option Exercise | +5.06K | — | — | 1.8% | 286.09K | 291.15K |
| Common Stock Direct | 9/2/2022 | S · Sale | −2.23K | $1.20 | $2.68K | 0.8% | 291.15K | 288.92K |
| Total | +2.83K | -$2.68K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
5.06K shares
Shares
+5.06K
Strike price
Held after
50.63K
Exercisable
—
9/1/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock5.06K shares | 9/1/2022 | M · Option Exercise | +5.06K | — | 50.63K |